Dystroglycan is a high affinity laminin-binding glycoprotein originally des
cribed as a member of the dystrophin-associated glycoprotein complex in mus
cle. We have demonstrated the presence of dystroglycan in the thyroid using
immunocytochemistry, immunoblots, ligand binding assays, and relative quan
titative RT-PCR. In intact rat thyroid glands, antibodies against the alpha
(extracellular, laminin-binding subunit) and beta (cytoplasmic/membrane bo
und) portions of the dystroglycan protein reacted at basolateral membranes
where they colocalized with laminin. Western-blotted protein from the Fisch
er rat thyroid cell line FRTL-5 reacted with both the alpha- and beta -dyst
roglycan antibodies. The alpha -dystroglycan-reactive band colocalized with
laminin-binding activity, and the protein and binding activity were decrea
sed by TSH. In contrast, in the culture medium of these cells, alpha -dystr
oglycan was increased by TSH. The beta -dystroglycan antibody recognized th
e full-length 43-kDa band and an approximately 30-kDa truncated form. The t
runcated form was reduced in cells cultured with TSH, whereas the full-leng
th form was not significantly diminished by TSH. Immunofluorescence of FRTL
-5 cells in the absence of TSH showed a colocalization of dystroglycan and
laminin. This was disrupted by the addition of TSH and was correlated to mo
rphologicaI changes. PCR amplification of complementary DNA with primer pai
ns from alpha- and beta -dystroglycan produced appropriately sized bands, w
hose sequence had identical protein-coding sequences and more than 96% nucl
eotide homology to mouse dystroglycan sequences. Relative quantitative RT-P
CR of beta -dystroglycan messenger RNA showed reduced expression in cells c
ultured with TSH. We conclude that dystroglycan is present in rat thyroid a
nd in FRTL5 rat thyroid eels and that TSH reduces its expression.